How Are Muscle Damage Markers Measured?

Muscle damage markers are circulating proteins and enzymes measured in blood to indicate disruption of skeletal muscle fibres. The most frequently reported in the research literature are creatine kinase (CK) and lactate dehydrogenase (LDH), both of which are intracellular enzymes that appear in plasma at elevated concentrations after mechanical or metabolic muscle insult. CK catalyses the reversible transfer of a phosphate group from creatine phosphate to ADP; LDH catalyses the interconversion of pyruvate and lactate. Neither is a muscle-specific molecule in the strict sense, and neither is a direct structural component of the contractile apparatus. They are surrogate analytes: their plasma concentration is interpreted as an indirect index of sarcolemmal integrity rather than as a measurement of damage itself. In the registered trial literature, CK and LDH are typically grouped together under the heading "muscle damage markers" and assayed alongside oxidative stress and inflammatory analytes in the same sample series [1].

The pathway context for this work is the exercise-induced oxidative stress and inflammatory signalling axis, in which reactive oxygen species generated during contraction are studied in relation to lipid peroxidation, antioxidant enzyme activity, and downstream cytokine release.

Research Studies

Creatine kinase and lactate dehydrogenase as muscle damage markers in exercise trials

In registered trial protocols, CK and LDH are listed as secondary outcome measures rather than primary endpoints. A study of a combined pterostilbene cocrystal, silybin, and nicotinamide riboside preparation (ccPT-SIL-NR) specifies blood malondialdehyde (MDA) as its primary outcome and enumerates muscle damage markers (LDH, CK) among its secondary objectives, alongside oxidative DNA damage (8-OHdG), F2-isoprostanes, total antioxidant capacity by FRAP assay, the glutathione ratio (GSH/GSSG), antioxidant enzyme activity (SOD, CAT, GPx), inflammatory markers (hsCRP, MCP-1, IL-6), cortisol, and creatinine [1]. The design places CK and LDH within a broader panel rather than treating them as standalone endpoints.

Astaxanthin and muscle damage markers after eccentric arm exercise

Astaxanthin is described in the trial literature as a potent antioxidant and anti-inflammatory carotenoid. Research examining whether astaxanthin could counteract exercise-induced muscle damage and improve exercise capacity reported inconsistent results [2]. A study was therefore designed to explore the impact of four weeks of astaxanthin supplementation on muscle damage markers, total antioxidant status, and a subjective marker of muscle pain. Twenty-four males were randomly assigned to 12 mg/day (n=8), 36 mg/day (n=9), or placebo (n=7). Blood samples were collected at rest, immediately after, and at 2, 24, 48, and 72 hours following eccentric arm exercise [2]. The repeated post-exercise sampling schedule illustrates the standard approach to measuring the time course of marker appearance and clearance.

Chickpea protein hydrolysate and muscle damage markers during a football tournament

A randomized, placebo-controlled crossover study evaluated a beverage containing chickpea protein hydrolysate in football players. Participants received the active beverage and a matched protein-containing placebo during two four-week intervention periods separated by a two-week washout. The study assessed biochemical safety parameters, antioxidant status, inflammatory biomarkers, lipid profile, lipid peroxidation, muscle damage markers, dietary intake, and body composition [3]. The crossover design allows each participant to serve as their own control, which is relevant when between-subject variability in baseline CK is large.

Sampling time course as a determinant of measured marker concentration

The trials above differ in when blood is drawn relative to the damaging bout. The astaxanthin protocol samples at rest and at five points up to 72 hours post-exercise [2], whereas the ccPT-SIL-NR protocol frames its outcomes around a single high-intensity exercise session [1]. Because CK and LDH kinetics differ, the sampling schedule is a design variable that affects the values obtained.

Muscle damage markers within multi-analyte panels

In all three registered studies, muscle damage markers are measured as one component of a wider biochemical panel rather than in isolation. The ccPT-SIL-NR study pairs LDH and CK with oxidative stress, antioxidant, inflammatory, endocrine, and renal measures [1]. The chickpea protein hydrolysate study pairs them with safety parameters, antioxidant status, inflammatory biomarkers, lipid profile, lipid peroxidation, dietary intake, and body composition [3]. This panel structure reflects the interpretation problem: CK and LDH are not specific to skeletal muscle, so concurrent measurement of other analytes is used to contextualise the values.

Subjective muscle pain alongside biochemical markers

The astaxanthin study measured a subjective marker of muscle pain in addition to biochemical muscle damage markers and total antioxidant status [2]. This combination is used because perceived soreness and circulating enzyme activity are not interchangeable measures and can diverge.

Inconsistency of prior findings as a stated rationale

The astaxanthin protocol states explicitly that research examining whether astaxanthin could counteract exercise-induced muscle damage and improve exercise capacity reported inconsistent results, and that this inconsistency motivated the study [2]. This is a direct statement about the state of the evidence for that compound in that context.

Evidence scope and limitations

The evidence summarised here consists of registered trial records and protocol descriptions. It does not provide completed results, effect sizes, or reference ranges for any marker. No animal-only or in vitro data are described in the evidence provided for these three studies; the populations named are human participants, specifically 24 males in the astaxanthin study [2] and football players in the chickpea protein hydrolysate study [3]. The population for the ccPT-SIL-NR study is not specified in the evidence provided [1].

If you are reading this for personal health reasons

The materials discussed on this page are sold for laboratory research use only. We do not provide dosing information or medical guidance of any kind. Anyone considering a compound for themselves should speak to a licensed clinician.

Sources

• [1] Effect of the Combination of Pterostilbene Cocrystal With Silybin and Nicotinamide Riboside on Exercise-Induced Oxidative Stress — ClinicalTrials.gov
• [2] Effects of Astaxanthin Supplementation — ClinicalTrials.gov
• [3] Effect of Chickpea Protein Hydrolysate Supplementation on Muscle Damage and Inflammatory Plasma Markers During a Football Tournament: A Randomized, Placebo-Controlled Crossover Trial — ClinicalTrials.gov